Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Ethical Issues01:27

Ethical Issues

2.3K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.3K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

469
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.

Medicina intensiva·2021
Same author

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.

Medicina intensiva·2021
Same author

Associations of thrombocytopenia, transaminase elevations, and transfusion with laboratory coagulation tests in women with preeclampsia: a cross-sectional study.

International journal of obstetric anesthesia·2021
Same author

Lemierre syndrome - treat with antibiotics, anticoagulants or both?

Journal of internal medicine·2020
Same author

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.

Journal of thrombosis and haemostasis : JTH·2017

Related Experiment Video

Updated: Feb 14, 2026

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain
04:24

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain

Published on: June 6, 2025

1.3K

Unresolved issues in anticoagulant therapy.

S Schulman1

  • 1Coagulation Unit, Division of Hematology, Department of Medicine, Karolinska Hospital, Sweden. sam.schulman@ks.se

Journal of Thrombosis and Haemostasis : JTH
|July 23, 2003
PubMed
Summary
This summary is machine-generated.

This review addresses uncertainties in anticoagulation therapy, including optimal use of thrombolytic agents and low-molecular-weight heparin in specific patient groups. It also examines anticoagulation duration, prophylaxis strategies, and controversies in pregnancy.

More Related Videos

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.9K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K

Related Experiment Videos

Last Updated: Feb 14, 2026

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain
04:24

Chuzhen Therapy as a Non-Invasive Traditional Chinese Therapy for Neck Pain

Published on: June 6, 2025

1.3K
Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.9K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Randomized clinical trials have advanced anticoagulation, enabling outpatient treatment for deep vein thrombosis using low-molecular-weight heparin.
  • Despite progress, significant uncertainties persist regarding optimal anticoagulation strategies in various clinical scenarios.

Purpose of the Study:

  • To review and clarify remaining uncertainties in anticoagulation therapy.
  • To discuss current debates and emerging evidence in anticoagulation management.
  • To highlight areas requiring further research.

Main Methods:

  • Literature review and synthesis of existing evidence on anticoagulation.
  • Analysis of clinical trial data and expert consensus.
  • Identification of controversies and knowledge gaps in anticoagulation practice.

Main Results:

  • Uncertainties exist regarding thrombolytic therapy use, low-molecular-weight heparin in obesity/renal failure, and optimal anticoagulation duration after venous thromboembolism.
  • Complexities arise from numerous recurrence risk factors, prompting investigation into lower intensity anticoagulation and novel drugs for secondary prophylaxis.
  • Gaps in evidence exist for stroke prophylaxis in non-valvular atrial fibrillation, anticoagulation during cardioversion, and thromboembolism prophylaxis in prosthetic heart valve patients, especially concerning surgical procedures.

Conclusions:

  • Further research is needed to refine anticoagulation protocols for specific patient populations and clinical situations.
  • Optimizing anticoagulation requires addressing uncertainties in duration, intensity, and drug selection for secondary prevention and high-risk groups.
  • Controversies surrounding anticoagulation in pregnancy and post-myocardial infarction prophylaxis warrant continued investigation and evidence generation.